Singlamedicos Pharma Private Limited
About Singlamedicos Pharma Private Limited
Data last updated:
Singlamedicos Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Keimed Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 July 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC168657. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was led by directors Viejay Kumar Singla and Arvind Kumar Venkat.
Its last annual general meeting (AGM) was held on 10 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at D.No 7 – 2 – 1740 K.Subbaiah Pillai Godowns Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2022, the company reported a revenue of ₹64.2 Cr, a growth of 83% compared to the previous year. For the same year it recorded a net loss of ₹2.47 Cr (net margin -3.8%) and EBITDA of -₹1.84 Cr (EBITDA margin -2.9%).
The company had about 42 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 1 subsidiary.
As per MCA filings, the company had satisfied charges of ₹16.35 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹8.98 Cr; the latest was in July 2021.
Company details
CIN history
Singlamedicos Pharma has one previous CIN (Corporate Identification Number): U51909CH2019PTC042622. The current CIN is U51909TG2019PTC168657, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909TG2019PTC168657 | Current |
| U51909CH2019PTC042622 | Previous |
Contact details
Singlamedicos Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No 7 – 2 – 1740 K.Subbaiah Pillai Godowns Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Singlamedicos Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Singlamedicos Pharma Private Limited
FY 2023 filings availableSinglamedicos Pharma Private Limited reported revenue of ₹64.2 Cr (up 83% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 83% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹64.2 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.84 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.47 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -2.9% | ||
| Net Profit Margin | -3.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Singlamedicos Pharma Private Limited, buy the company report.
Board of directors of Singlamedicos Pharma Private Limited
Singlamedicos Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 01 Oct 2020 | 6 Years 0 Months | As last reported |
| Viejay Kumar Singla | Director | 15 Jul 2019 | 7 Years 3 Months | As last reported |
Auditor
Singlamedicos Pharma Private Limited is audited by GOEL ARUN & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOEL ARUN & ASSOCIATES | FY 2022 | 523071 |
Shareholding
The shareholding of Singlamedicos Pharma Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Singlamedicos Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jun 2022 | 100597439 | Hdfc Bank Limited | ₹35 Lakh | Satisfied | |
| 20 Aug 2020 | 100361366 | Hdfc Bank Limited | ₹16 Cr | Satisfied |
To see the full charge records of Singlamedicos Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Singlamedicos Pharma Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹8.98 Cr; the latest was in July 2021.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2020 | Funding round | ₹8.8 Cr | Investors: Keimed Private Limited , 2 individuals |
| May 2020 | Funding round | ₹18 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Singlamedicos Pharma Private Limited has 2 court cases on record: 2 filed by Singlamedicos Pharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Singlamedicos Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Singlamedicos Pharma Private Limited was last rated by Care on 07 Oct 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Oct 2022 |
To see the full credit ratings and regulatory alerts of Singlamedicos Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Singlamedicos Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Singlamedicos Pharma has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Tirath Singh & Bros Agencies Private Limited | U24299CH2021PTC043522 |
To see the full group structure of Singlamedicos Pharma Private Limited, buy the company report.
Employees & EPFO
Singlamedicos Pharma Private Limited has a workforce of 42 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Singlamedicos Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Singlamedicos Pharma Private Limited, buy the company report.
Recent activity
Singlamedicos Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Gian Chand Singla ceased to be Director on 04 Jun 2023.
Frequently asked questions
Singlamedicos Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Singlamedicos Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 July 2019 and is registered under CIN U51909TG2019PTC168657. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Singlamedicos Pharma was incorporated on 15 July 2019. It is registered with the Registrar of Companies, Hyderabad.
Singlamedicos Pharma had 2 directors:
- Arvind Kumar Venkat - Nominee Director
- Viejay Kumar Singla - Director
The CIN (Corporate Identification Number) of Singlamedicos Pharma is U51909TG2019PTC168657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Singlamedicos Pharma is at D.No 7 – 2 – 1740 K.Subbaiah Pillai Godowns Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018.
The latest financial statements of Singlamedicos Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 10 August 2023. Year-wise statements from FY 2020 are in the company report.
No. Singlamedicos Pharma has 1 GST registration on record and it is cancelled or inactive.
Singlamedicos Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
Singlamedicos Pharma has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹8.98 Cr; the latest was in July 2021.